Ellen Murphy
10Patents
4h-index
15Co-inventors
53Inventor score
Filing activity: Mar 5, 1999 → Oct 15, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6569830B1 | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains | Chemistry; Metallurgy | 18 | Expired |
| US7122514B2 | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains | Chemistry; Metallurgy | 12 | Expired |
| US8568735B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 10 | Active |
| US8889145B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 5 | Active |
| US7078377B1 | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains | Chemistry; Metallurgy | 4 | Expired |
| US9114105B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 3 | Active |
| US8198231B2 | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains | Chemistry; Metallurgy | 0 | Active |
| US8071112B2 | Compositions and methods of use of ORF-1358 from beta-hemolytic streptococcal strains | Emerging Cross-Sectional Technologies | 0 | Active |
| US7914798B2 | Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains | Emerging Cross-Sectional Technologies | 0 | Active |
| US7754226B2 | Compositions and methods of use of ORF 554 from beta hemolytic streptococcal strains | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.